Crossover Study

Study,time,analysis,treatments,trials,outcomes,disease,characteristic,review,primary outcome,exposure,types,MeSH terms,case-crossover study.

Treatment period,drug,sensitivity,range,healthy volunteers,case-crossover design,crossover studies,study arm,case-control study,randomized crossover study,clinical trials.

Secondary outcome,events,acute events,individual characteristics,health risks,systematic review,washout,washout periods,standard deviation,cross-over design,cardiovascular effects.

Matched case-control study,study participants,observational studies,study subjects,treatment effects,Crossover trials,parallel group trial,analysis of crossover trials,long-term exposures,cardiovascular events,clinical characteristics,baseline characteristics,health,National Institutes of Health,Annu Rev Public Health,active drug,mark,Case-crossover analysis,chronic diseases,allocation,exercise,age range,National Library of Medicine,Maclure M,Mittleman MA,attributable fraction,correlation coefficient,parallel design,Acute effects,sequence of interventions,study sponsor,Cross-over studies,azithromycin in treatment period,estimate of treatment effect,intended treatment,placebo in treatment period,treatment by period interaction,treatment sequences,randomised crossover trial,trial designs,primary outcome measure,binary outcome,short-term exposure,exposure to air pollution,Adverse events,type of eligibility criteria,arm type,type of intervention model,Food and Drug Administration,U.S. Food and Drug Administration,mark on consolidation,DLD-generated true-positive mark,true-positive mark,Time of death,control time windows,participant analysis,QC review,cardiovascular diseases,2-week washout,lesion sensitivity,image sensitivity,random allocation sequence,allocation ratio,exercise echocardiography,sildenafil during exercise,score range.